Nuclear Medicine Radioisotopes Market Clinical Development and Industry Growth 2019 to 2023

The global nuclear medicine radioisotopes market has been estimated to reach USD 13.9 billion in 2017.The market is expected to register a CAGR of 12.3% during the forecast period 2019 to 2023.

Nuclear Medicine Radioisotopes

The Global Nuclear Medicine Radioisotopes Marekt Report provides a complete analysis of the market. The Report focuses on manufacturers, suppliers, segmentation according to the application, major players, customers, opportunities, future roadmap, and furthermore. The competitive data type analysis includes capacity, market share, profit margin, market growth, consumer consumption, imports, exports, revenue, and etc. Marketing strategies, policies, industry chain that are changing the wave of the market are also catered in the report.

The global nuclear medicine radioisotopes market has been estimated to reach USD 13.9 billion in 2017.The market is expected to register a CAGR of 12.3% during the forecast period 2019 to 2023.


Click the link to get a free Sample Copy of the Report:

Rising SPECT and PET Applications

The field of nuclear medicine is dominated by the applications related to positron emission tomography (PET) and single-photon emission computerized tomography (SPECT). Growing interest of PET technology in cardiac and neurological disorders is expected to fuel the market growth. More than 60% of SPECT procedures are performed in cardiology and in addition, orthopedics, oncology and infection imaging are emerging as areas that can benefit from the same. Applications are further increased through the inclusion of advancements in computed tomography (CT), making nuclear medicine as a rising choice for disease diagnosis. In addition, factors such as rising incidences of cardiac and cancer cases along-with rising awareness of public for the same, drives the nuclear medicine market.

High Capital Investments is involved

One of the major hindrance for the nuclear medicine radioisotopes market is the high capital investments required for the generation of radionuclide. Cyclotron initial investment is very high which followed by renovation and installation and further annual operating costs are involved. With high investment, the cost of imaging and treatment overall becomes a factor of high expenditure especially in developing markets. These factors including unclear regulatory guidelines and varied reimbursement policies and short half-life of radiopharmaceuticals restricts the growth of this market.

(Special Offer: Get flat 15% discount on this report)

Inquire for Discount:

North America to Dominate this Market

The global nuclear medicine radioisotopes market is segmented by types of radioisotopes, by applications in different indications and geography. Geographically, the market is segmented into North America, Europe, Asia-Pacific, the Middle East and Africa and South America.

North America dominated the nuclear medicine radioisotopes market with approximately 40% of the global market share in 2017. The factors such as well-established healthcare facilities and the rise in geriatric population, with rising awareness among people for nuclear medicine treatments and diagnosis contribute to the growth of this market in the region. Moreover, Asia-Pacific region was estimated to register the fastest CAGR through the forecast period, 2018-2023.

Regional Analysis For Nuclear Medicine Radioisotopes Market:

For comprehensive understanding of market dynamics, Nuclear Medicine Radioisotopes Market is analyzed across key geographies namely: North America, US, Europe, Australia, Mexico, UK, India and others. Each of these regions is analyzed on basis of market findings across major countries in these regions for a macro-level understanding of the market.

Browse the Full report description and TOC at:

What are the market factors that are explained in the report?

Key Strategic Developments: The study also includes the key strategic developments of the market, comprising R&D, new product launch, M&A, agreements, collaborations, partnerships, joint ventures, and regional growth of the leading competitors operating in the market on a global and regional scale.

Key Market Features: The report evaluated key market features, including revenue, price, capacity, capacity utilization rate, gross, production, production rate, consumption, import/export, supply/demand, cost, market share, CAGR, and gross margin. In addition, the study offers a comprehensive study of the key market dynamics and their latest trends, along with pertinent market segments and sub-segments.

Analytical Tools: The Global Nuclear Medicine Radioisotopes Market report includes the accurately studied and assessed data of the key industry players and their scope in the market by means of a number of analytical tools. The analytical tools such as Porter’s five forces analysis, feasibility study, and investment return analysis have been used to analyzed the growth of the key players operating in the market.

Finally, Nuclear Medicine Radioisotopes Market report is the believable source for gaining the Market research that will exponentially accelerate your business. The report gives the principle locale, economic situations with the item value, benefit, limit, generation, supply, request and Market development rate and figure and so on. This report additionally Present new task SWOT examination, speculation attainability investigation, and venture return investigation.

Reasons to Purchase this report:

-To understand the impact of various applications on the market

-Analyzing various perspectives of the market with the help of Porters five forces analysis

-To understand the dominating application in the market

-Countries expected to witness the fastest growth during the forecast period

-Identify the latest developments, market shares, and strategies employed by the major market players

-3-month analyst support, along with the Market Estimate sheet in excel

Media Contact US:

Irfan Tamboli (Head of Sales) – Market Insights Reports

Phone: + 1704 266 3234 | +91-750-707-8687 |